Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Potential to improve the therapeutic situation of HCC patients - The influence of Regorafenib and Lenvatinib treatment in combination with Cdk5 inhibition in HCC.

#2019

PMU Authors
Maximilian Alexander Ardelt, Petra Huber-Cantonati, Johanna Pachmayr

All Authors
Maximilian Alexander Ardelt, Petra Huber-Cantonati, Johanna Pachmayr

Abstract

We are sorry. The full text is not available.